United StatesUnited States Institutional Investor

US Large Cap Strategy

A core equities strategy focused on US large cap companies with strong prospects and attractive valuations.

Capital at risk. Past performance is not a reliable indicator of current or future results and should not be the sole factor of consideration when selecting a product or strategy.

Information regarding key risk considerations for this Impax strategy can be viewed here.

AUM
As of 31 March 2025
US$1,275m
Holdings
30-60
Launch date
December 2016
Portfolio managers
Amber Fairbanks, CFA®
Joseph Cordi, CFA®

Overview

The US Large Cap strategy seeks to achieve capital growth over 5+ years by investing in US companies addressing long-term secular growth trends likely to benefit from the transition to a more sustainable economy.

These long-term growth trends can include: resource efficiency, electrification, evolution of cloud computing, clean water, access to finance and transformative health care.

Strong prospects

Bottom-up stock selection focuses on identifying companies with favourable business trends, superior management, and potential catalysts that can drive stock price appreciation.

Valuation

Disciplined valuation process evaluates long-term upside potential and downside risk.

Sustainability

Proprietary tools and research are integrated to better manage sustainability risks and identify investment opportunities.

Discrete performance (%) USD

(As of 31/05/2025)
Past performance does not predict future returns.
 2025 YTD20242023202220212020
US Large Cap Composite (gross)0.0114.7720.92-19.1831.8124.93
US Large Cap Composite (net)-0.2614.0320.13-19.7030.9524.11
S&P 5001.0625.0226.29-18.1128.7118.40

Figures refer to the past and that past performance is not a reliable indicator of future results. The value of investments, and the income derived from them, can fall as well as rise. Investors may get back less than invested. All data as at reporting date indicated above, unless otherwise stated. Performance is shown net of ongoing charges and portfolio costs, with net-income reinvested where applicable. Source: FactSet, Bloomberg, WM Reuters.

S&P 500 Index is an unmanaged index of large capitalization common stocks.

Data is in USD. Composite figures are presented both gross and net of management fees and include the reinvestment of all income. Impax Asset Management claims compliance with Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. Please click here for the GIPS® Disclosure for additional information on the composite.

Investment Vehicles

Close-up of hens and chickens succulent plant

Impax Large Cap Fund

Focused on companies with strong prospects and attractive valuations.

View Fund

Portfolio Managers

Image of Amber Fairbanks

Amber Fairbanks, CFA®

Portfolio Manager

Amber is a co-Portfolio Manager of the Impax Global Social Leaders strategy and US Large Cap strategy. Amber researches stocks focusing on the consumer discretionary and staples sectors.

Before joining Impax Asset Management in 2023, Amber worked at Mirova where she was co-manager of the Mirova International Sustainable Equity, US Sustainable Equity and Global Sustainable Equity funds. Prior to joining Mirova in October 2018, Amber was a portfolio manager and analyst at Zevin Asset Management for over a decade. Previously, she was an analyst at J.L. Kaplan Associates, a division of Evergreen Investments, and worked for Delta Partners, a Boston-based hedge fund.

Amber received her MBA from Boston College Carroll School of Management and has a BS in environmental science from the University of Massachusetts Amherst. Amber is a CFA® Charterholder, and a member of the Chartered Financial Analysts Institute and the Boston Security Analysts Society.

Recent Insights

Additional Insights

Joseph Cordi, CFA®

Portfolio Manager

Joseph is a co-Portfolio Manager of the US Large Cap strategy and a lead contributor to Impax’s healthcare sector research.

Before joining Impax in 2022, Joseph worked in a similar role for Citi Investment Management where he covered the healthcare, consumer staples, and financials sectors. He also supported the firm’s core, dividend, and thematic strategies.

Joseph has a master’s degree in biotechnology from Johns Hopkins University and a bachelor’s degree from George Washington University, where he graduated magna cum laude. He is a CFA® Charterholder and holds the FINRA Series 7 and 66 registrations. Joseph is a registered representative of Foreside Financial Services, LLC.

Authored Insights

Scroll to top
To get started, please select your location and investor type below.

If you are invested in Impax Funds – regardless of share class (Investor, Institutional, or Class A) or account type (individual, business or other entity) please select Impax Funds Investor as your Investor Type.

Access Impax Asset Management Limited’s Form CRS here.

Important Information

I confirm that my investor role is [investor_type] and I am based in [investor_country] and I have read and understood the important information, privacy policy and terms and conditions which govern the use of this website.

Risk Warning

Capital at risk. The value of investments may go up or down and is not guaranteed.